Agenus | AGEN - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
AbbVie USD 688M 58M 2026-09
Agenus USD 14.67M 1.35M 2026-03
Amgen USD 653M 94.99B 2026-09
AstraZeneca USD 371M 31M 2026-09
Bristol-Myers Squibb USD 403M 4M 2026-09
CSL USD 215M 111M 2025-12
Eli Lilly USD 316M 201.3M 2026-09
Gilead Sciences USD 269M 22M 2026-09
GlaxoSmithKline GBP 219M 98M 2026-09
Glaxosmithkline GBP 264.74M 72.01M 2026-09
Incyte USD 605K 23K 2026-09
Intrexon USD 2K 5K 2024-06
J&J USD 43M 25M 2026-03
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Karyopharm Therapeutics USD 12.55M 66K 2026-03
MacroGenics USD 4.4M 493K 2026-06
Merck EUR 137M 33M 2026-06
Merck USD 525M 46M 2026-06
Northwest Biotherapeutics USD 1.52M 276K 2024-03
Novartis USD 468M 6M 2026-09
Novavax USD 5.82M 342K 2025-12
Pfizer USD 662M 5M 2026-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Rigel Pharmaceuticals USD 2.06M 31K 2024-09
Sangamo BioSciences 97.56M 11.39M 2025-06
Veracyte USD 2K 1000 2023-12